Assignee profile:

SANTEN SAS

City:

Evry

Country:

France

Published Applications:

16

Last publication date:

2021-04-15

Patent Grants:

16

Last grant date:

2022-09-27

Top Inventors for applications by SANTEN SAS

These are the the leading inventors for applications assigned to SANTEN SAS:

Recent patent applications by SANTEN SAS

SANTEN SAS based in Evry, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-04-15 ✅ Patent 11,452,739 granted on 2022-09-27
US20210106610A1
Human necessities

Polysaccharides for the treatment of ocular conditions

#2 | 2021-02-11 ✅ Patent 11,612,658 granted on 2023-03-28
US20210038721A1
Human necessities

Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same

#3 | 2020-01-02 ✅ Patent 10,842,873 granted on 2020-11-24
US20200000924A9
Human necessities

COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS

#4 | 2019-01-24 ✅ Patent 10,842,873 granted on 2020-11-24
US20190022231A1
Human necessities

Methods for preparing oil-in-water emulsions comprising cetalkonium chloride

#5 | 2016-03-24 ✅ Patent 9,956,289 granted on 2018-05-01
US20160082107A1
Human necessities

Emulsion compositions containing quaternary ammonium compounds

#6 | 2015-01-22 ✅ Patent 9,682,147 granted on 2017-06-20
US20150025020A1
Human necessities

Self-preserved oil dispersions comprising boric acid

#7 | 2013-12-19 ✅ Patent 9,220,694 granted on 2015-12-29
US20130337019A1
Human necessities

Emulsion compositions containing cetalkonium chloride

#8 | 2013-06-27 ✅ Patent 9,107,822 granted on 2015-08-18
US20130164285A1
Human necessities

Water-in oil type emulsion for treating a disease of the eye

#9 | 2012-09-06 ✅ Patent 9,072,750 granted on 2015-07-07
US20120225939A1
Human necessities

Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions

#10 | 2011-12-29 ✅ Patent 9,089,480 granted on 2015-07-28
US20110319488A1
Human necessities

Anionic oil-in-water emulsions containing prostaglandins and uses thereof

#11 | 2011-05-26 ✅ Patent 9,616,016 granted on 2017-04-11
US20110124616A1
Human necessities

Method for treating retinal conditions using an intraocular tamponade

#12 | 2011-05-19 ✅ Patent 9,555,045 granted on 2017-01-31
US20110118349A1
Human necessities

Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

#13 | 2010-11-11 ✅ Patent 8,623,852 granted on 2014-01-07
US20100286065A1
Human necessities

Topical methods and compositions for the treatment of eye diseases and conditions

#14 | 2008-08-14 ✅ Patent 9,132,071 granted on 2015-09-15
US20080194532A1
Human necessities

Compositions containing quaternary ammonium compounds

#15 | 2008-07-31 ✅ Patent 9,364,461 granted on 2016-06-14
US20080181867A1
Human necessities

Process for manufacturing ophthalmic oil-in-water emulsions

#16 | 2007-12-06 ✅ Patent 9,192,567 granted on 2015-11-24
US20070281913A1
Human necessities

Method for treating eye disease or conditions affecting the posterior segment of the eye

Also check out SANTEN SAS's (Evry, France) applicant profile with 6 patent applications submitted.

AssigneeID:

309376 ⎘